MRNA Moderna

NEUTRAL Impact: 3/10 COURT-RULING
Horizon weeks Filed Mar 30, 2026 Processed 2mo ago Court View Ruling on CourtListener
Court ruling (district)
Latest settled — T+20d
MRNA ▼ -2.31% at T+20d
NEUTRAL call ✗ call lost -2.31% · α vs SPY -14.90% · entry $48.16 → $47.05
Next anchor: T+60d in 14d
Currently $47.73 · -0.90% from $48.16 entry
Entry anchored
Mar 27, 03:59 PM ET
via Databento tick
T+1d
+5.40%
call +5.40% · α +2.51%
$50.76
settled 2mo ago
T+5d
+3.70%
call +3.70% · α -0.60%
$49.94
settled 2mo ago
T+20d
-2.31%
call -2.31% · α -14.90%
$47.05
settled 6w ago
T+60d
call — · α —
in 14d

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable

Court Ruling Details

Court
United States District Court for the District of Delaware
Court Level
District
Case Type
other
Ruling Type
other
Outcome
NULL
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW

Actionable Insight

Monitor for subsequent filings or public statements from Moderna regarding the litigation. Given the involvement of Northwestern University, this could relate to intellectual property, but without further details, material impact cannot be assessed.

Key Facts

  • Case: Northwestern University v. Moderna, Inc. et al, filed in U.S. District Court for the District of Delaware
  • Date filed: 2026-03-30
  • Status: unknown
  • Nature of suit or ruling details not available in provided text

Financial Impact

Unknown — no financial figures or ruling details provided

Risk Factors

  • Potential IP or patent dispute with academic institution, which could affect future product development if substantiated
  • Risk of future financial exposure or injunction if the case proceeds and ruling is adverse

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
10% bullish (30 analysts)

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-2eno758p-MRNA
9 reports for MRNA
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +14.15%Mar 5, 2026
Filters
Rows
Reports for MRNA — sortable, filterable
Type Now
May 31, 2026
9d ago
ANALYST-UPGRADE
BULLISH ★ 1/10
$39.50 $43.64▲ +10.48%▲ +8.89%$47.73 (+20.83%)
May 22, 2026
18d ago
Insider Cluster
NEUTRAL ★ 2/10
$46.99 $45.60▼ −2.96%▼ −4.17%$47.73 (+1.57%)
May 21, 2026
19d ago
144
NEUTRAL ★ 2/10
$47.19 $47.05▼ −0.30%▼ −2.15%$47.73 (+1.14%)
May 8, 2026
4w ago
144
NEUTRAL ★ 2/10
$54.31 $50.03▼ −7.88%▼ −9.35%$47.73 (−12.12%)
May 1, 2026
5w ago
ANALYST-UPGRADE
NEUTRAL ★ 1/10
$39.50 $43.64▲ +10.48%▲ +8.89%$47.73 (+20.83%)
Mar 30, 2026
10w ago
Court Ruling
NEUTRAL ★ 3/10
$48.16 $49.94▲ +3.70%▼ −0.60%$47.73 (−0.90%)
Mar 16, 2026
12w ago
DEFA14A
NEUTRAL ★ 3/10
$53.82 $51.28▼ −4.72%▼ −2.06%$47.73 (−11.32%)
Mar 5, 2026
13w ago
8-K
BEARISH ★ 8/10
$53.65 $53.20▲ +0.84%▼ −1.40%$47.73 (+11.04%)
Feb 28, 2026
14w ago
Institutional Cluster
BULLISH ★ 7/10
$52.82 $55.73▲ +5.51%▲ +6.72%$47.73 (−9.64%)
Showing 9 of 9

US Market Status

Market Closed — Opens Thu (10h 58m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access